The leading point-of-care wound imaging devices for the detection of the presence and location of elevated bacterial loads and for accurate digital wound measurement.

MolecuLight i:X 

 Wound Imaging Device

The MolecuLight i:X allows clinicians to quickly, safely and easily visualize bacteria and measure wounds at the point of care.

What does MolecuLight i:X do?

Visualise Bacteria

MolecuLight i:X allows clinicians to focus on potentially harmful levels of bacteria with the guidance of fluorescence imaging.

Measure Wound Area

MolecuLight i:X provides clinicians with a comprehensive toolkit for digital wound area measurement and documentation.

See What You’re Missing

  1. When explaining about how it works, I’ve a few suggestions below in red.

The MolecuLight i:X emits a precise wavelength of safe violet light, which interacts with the wound tissue and bacteria causing the wound and surrounding skin to emit a green fluorescence (i.e. collagen) and potentially harmful bacteria to emit a red fluorescence (i.e. porphyrins).1 Cyan fluorescence indicates the presence of Pseudomonas aeruginosa1In real-time, MolecuLight i:X captures these red, green and cyan fluorescence signals using specialized optical components to filter out the violet light, and displays the resultant image immediately on the display screen (FL-image).1,2 The MolecuLight i:X is precisely calibrated to detect fluorescent bacteria at levels of ≥ 104 CFU/g on a quantitative scale or predominantly moderate to heavy growth on a semi-quantitative scale.1 Knowledge about bacterial burden can help in all areas of wound care, promoting healing3 and antimicrobial stewardship4.

New peer-reviewed publications featuring MolecuLight appeared in:


1. Le L, Baer M, Briggs P, Bullock N, Cole W, DiMarco D, Hamil R, Harrell K, Kasper M, Li W, Patel K, Sabo M, Thibodeaux K, Serena TE. Diagnostic Accuracy of Point-of-Care Fluorescence Imaging for the Detection of Bacterial Burden in Wounds: Results from the 350-Patient Fluorescence Imaging Assessment and Guidance Trial. Adv Wound Care (New Rochelle). 2021 Mar;10(3):123-136.2. Rennie MY, Dunham D, Lindvere-Teene L, Raizman R, Hill R, Linden R. Understanding Real-Time Fluorescence Signals from Bacteria and Wound Tissues Observed with the MolecuLight i:XTM. Diagnostics (Basel). 2019 Feb 26;9(1):22.3. Rahma S, Woods J, Brown S, Nixon J, Russell D. The Use of Point-of-Care Bacterial Autofluorescence Imaging in the Management of Diabetic Foot Ulcers: A Pilot Randomized Controlled Trial. Diabetes Care. 2022 Jul 7;45(7):1601-1609.4. Price N. Routine Fluorescence Imaging to Detect Wound Bacteria Reduces Antibiotic Use and Antimicrobial Dressing Expenditure While Improving Healing Rates: Retrospective Analysis of 229 Foot Ulcers. Diagnostics (Basel). 2020 Nov 10;10(11):927.